Explore more Articles in

Stock Sectors

Markets Await Trade Deals as Trump Makes New Tariff Threats

Dollar edges higher, gold slips despite confusion and renewed trade tensions Trump delays tariff deadline to August 1, says trade deals are close Wall Street hits...

Gold Prices Under Pressure as Tariff Talks Offset Geopolitical Risks

Tariff Negotiations Weigh Down on Gold Gold () rose slightly on Friday as markets adjusted amid evolving trade headlines. However, it pulled back during the...

Oil Price Retreats but Bullish Technicals Suggest Upside Ahead

The NA session kicks off quietly, with subdued volumes as American traders take the day off, giving markets a breather after the upside surprise...

Stocks Week Ahead: Can Small-Business Optimism, Inflation Clues Keep Bulls Alive?

There’s not much on this week’s economic calendar. The only big event was supposed to occur on Wednesday, July 9. That would have been...
Energy Stocks

Oil Prices Dip on Confirmation of Inventory Build

prices opened weaker today following Wednesday’s release of U.S. oil inventory data that confirmed API’s estimate of a build. Regardless of the fact that...
Energy Stocks

Natural Gas: Hotter July Forecasts May Test Storage and Supply Balance

The market continues to navigate a complex mix of seasonal demand patterns, weather volatility, and fluctuating supply and demand. To better understand where...
Energy Stocks

Natural Gas Prices Risk Further Decline Amid Rising Supply and Weak Demand

in the United States fell to $3.40/MMBtu, the lowest level in six weeks, due to increased production and subdued demand. Mild weather conditions...
Energy Stocks

Oil Gains May Be Short-Lived With OPEC+ Set to Raise Supply Again

The trade deal between the US and Vietnam boosted oil prices. However, with OPEC+ set to decide on August output levels, the move higher...
BioTech

How Zevra’s Miplyffa Could Transform Investment Strategies – Zevra Therapeutics (NASDAQ:ZVRA)

Zevra Therapeutics, Inc. ZVRA is turning a quiet FDA approval into a broader comeback story. HC Wainwright initiated coverage on the rare disease drugmaker...
BioTech

Merck’s Hypertension Drug On FDA Fast Track For Label Expansion – Merck & Co (NYSE:MRK)

The U.S. Food and Drug Administration (FDA) has accepted and granted priority review for Merck & Co. Inc.’s MRK new supplemental Biologics License Application...
1234...29Page 3 of 29

- A word from our sponsors -

Most Popular

Disclaimer: The content provided is for informational purposes only. We aim to keep the content current and accurate by updating it frequently. Sometimes the actual data can differ from what's stated on our website. Buttonwoodnews.com is an independent platform. While we are independent, we may be compensated for advertisements, sponsored products, or when you click on a link on our website. The contributors and authors are not registered or certified financial advisors. You should consult a financial professional before making any financial decisions.

Copyright © Button Wood News.